Hubert Buczkowski

Hubert Buczkowski

Auto-generated profile, based on publicly available information

Hubert Buczkowski

High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2021 in Journal of General Virology
Verified
Journal Article
Open access
KDKatherine Davies
Katherine Davies
HBHubert Buczkowski
Hubert Buczkowski
SWStephen R Welch
Stephen R Welch
NGNicole Green
Nicole Green
DMDamian Mawer
Damian Mawer
MKMarian J. Killip
Marian J. Killip
Infectious SARS-CoV-2 can be recovered from the oral cavities and saliva of COVID-19 patients with potential implications for disease transmission. Reducing viral load in patient saliva using antiviral mouthwashes may therefore have a role as a control measure in limiting virus spread, particularly in dental settings. Here, the efficacy of SARS-CoV-2 inactivation by seven commercially available mouthwashes with a range of active ingredients were evaluated in vitro. We demonstrate ≥4.1 to ≥5.5 log10 reduction in SARS-CoV-2 titre following a 1 min treatment with commercially available mouthwashes containing 0.01–0.02 % stabilised hypochlorous acid or 0.58 % povidone iodine, and non-specialist mouthwashes with both alcohol-based and alcohol-free formulations designed for home use. In contrast, products containing 1.5 % hydrogen peroxide or 0.2 % chlorhexidine gluconate were ineffective against SARS-CoV-2 in these tests. This study contributes to the growing body of evidence surrounding virucidal efficacy of mouthwashes/oral rinses against SARS-CoV-2, and has important applications in reducing risk associated with aerosol generating procedures in dentistry and potentially for infection control more widely.